'bivalirudin' can also refer to...



bivalirudin n.

Bivalirudin and argatroban

Is bivalirudin just an expensive heparin?

The role of bivalirudin in percutaneous coronary intervention

The role of bivalirudin in percutaneous coronary intervention

Improving outcomes with bivalirudin in primary percutaneous coronary intervention

Does ‘SWITCHing’ from heparin to bivalirudin monotherapy result in a bleeding benefit?

Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction

Profile of bleeding and ischaemic complications with bivalirudin and unfractionated heparin after percutaneous coronary intervention†

Regulation of PAR-1 in patients undergoing percutaneous coronary intervention: effects of unfractionated heparin and bivalirudin

Safety and effectiveness of bivalirudin in routine care of patients undergoing percutaneous coronary intervention

The comparative efficacy of bivalirudin is markedly attenuated by use of radial access: insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium

Impact of bivalirudin or unfractionated heparin on platelet aggregation in patients pretreated with 600 mg clopidogrel undergoing elective percutaneous coronary intervention

Bivalirudin, glycoprotein inhibitor, and heparin use and association with outcomes of primary percutaneous coronary intervention in the United Kingdom

Bivalirudin vs. unfractionated heparin during percutaneous coronary interventions in patients with stable and unstable angina pectoris: 1-year results of the ISAR-REACT 3 trial

Bivalirudin is superior to heparins alone with bailout GP IIb/IIIa inhibitors in patients with ST-segment elevation myocardial infarction transported emergently for primary percutaneous coronary intervention: a pre-specified analysis from the EUROMAX trial


More Like This

Show all results sharing this subject:

  • Clinical Pharmacology and Therapeutics


Show Summary Details

Quick Reference

A synthetic anticoagulant peptide (20 aa), based on hirudin, a specific and reversible thrombin inhibitor, that will bind to the catalytic site and to the anion-binding exosite of both circulating and clot-bound thrombin. TN Angiomax.

Subjects: Clinical Pharmacology and Therapeutics.

Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.